UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma

Clinical cancer research, 2012-04, Vol.18 (8), p.2290-2300

2012

Volltextzugriff (PDF)

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

Hepatology international, 2017-03, Vol.11 (2), p.199-208

2017

Volltextzugriff (PDF)

Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer

Clinical and translational science, 2019-09, Vol.12 (5), p.459-469

2019

Volltextzugriff (PDF)

Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial

Clinical cancer research, 2016-10, Vol.22 (19), p.4870-4879

2016

Volltextzugriff (PDF)

Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase III DECISION Trial

Clinical cancer research, 2019-12, Vol.25 (24), p.7370-7380

2019

Volltextzugriff (PDF)

Assembly and Activation of Site-Specific Recombination Complexes

Proceedings of the National Academy of Sciences - PNAS, 2000-07, Vol.97 (14), p.7760-7765

2000

Volltextzugriff (PDF)

Protein-DNA Complexes in Mycobacteriophage L5 Integrative Recombination

Journal of Bacteriology, 1999-01, Vol.181 (2), p.454-461

1999

Volltextzugriff (PDF)

Positions of strand exchange in mycobacteriophage L5 integration and characterization of the attB site

Journal of Bacteriology, 1996-09, Vol.178 (18), p.5533-5536

1996

Volltextzugriff (PDF)

The role of supercoiling in mycobacteriophage L5 integrative recombination

Nucleic acids research, 1998-09, Vol.26 (17), p.4012-4018

1998

Volltextzugriff (PDF)

A Systems Biology Approach to Target Identification and Validation for Human Chronic Disease Drug Discovery

Modern Biopharmaceuticals, 2005, p.99-125

2005

Volltextzugriff (PDF)

Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation

PloS one, 2013-01, Vol.8 (1), p.e52449

2013

Volltextzugriff (PDF)

Sex-Specific Role for the Long Non-coding RNA LINC00473 in Depression

Neuron (Cambridge, Mass.), 2020-06, Vol.106 (6), p.912-926.e5

2020

Volltextzugriff (PDF)

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3312-3318

2009

Volltextzugriff (PDF)

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

Annals of internal medicine, 2015-09, Vol.163 (6), p.461-464

2015

Volltextzugriff (PDF)

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

Annals of oncology, 2017-09, Vol.28 (9), p.2169-2178

2017

Volltextzugriff (PDF)

Investigating Resistance to Antidepressants in Animal Models

Neuroscience, 2024-06, Vol.548, p.69-80

2024

Volltextzugriff (PDF)

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors

Molecular cancer therapeutics, 2020-02, Vol.19 (2), p.468-478

2020

Volltextzugriff (PDF)

Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Cancer research (Chicago, Ill.), 2019-01, Vol.79 (1), p.231-241

2019

Volltextzugriff (PDF)

Aberrant H3.3 dynamics in NAc promote vulnerability to depressive-like behavior

Proceedings of the National Academy of Sciences - PNAS, 2016-11, Vol.113 (44), p.12562-12567

2016

Volltextzugriff (PDF)

An integrative approach to understanding the evolution and diversity of Copiapoa (Cactaceae), a threatened endemic Chilean genus from the Atacama Desert

American journal of botany, 2015-09, Vol.102 (9), p.1506-1520

2015

Volltextzugriff (PDF)

Molecular phylogeny of the large South American genus Eriosyce (Notocacteae, Cactaceae): Generic delimitation and proposed changes in infrageneric and species ranks

Taxon, 2019-06, Vol.68 (3), p.557-573

2019

Volltextzugriff (PDF)

Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes

Proceedings of the National Academy of Sciences - PNAS, 2015-05, Vol.112 (20), p.6431-6436

2015

Volltextzugriff (PDF)

PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors

The pharmacogenomics journal, 2022-02, Vol.22 (1), p.82-88

2022

Volltextzugriff (PDF)

Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial

Molecular cancer therapeutics, 2020-01, Vol.19 (1), p.312-317

2020

Volltextzugriff (PDF)

Accelerated magnetocardiography in the evaluation of patients with suspected cardiac ischemia: The MAGNETO trial

American heart journal plus, 2024-04, Vol.40, p.100372-100372, Article 100372

2024

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer

Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial

Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase III DECISION Trial

Assembly and Activation of Site-Specific Recombination Complexes

Protein-DNA Complexes in Mycobacteriophage L5 Integrative Recombination

Positions of strand exchange in mycobacteriophage L5 integration and characterization of the attB site

The role of supercoiling in mycobacteriophage L5 integrative recombination

A Systems Biology Approach to Target Identification and Validation for Human Chronic Disease Drug Discovery

Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation

Sex-Specific Role for the Long Non-coding RNA LINC00473 in Depression

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

Investigating Resistance to Antidepressants in Animal Models

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors

Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Aberrant H3.3 dynamics in NAc promote vulnerability to depressive-like behavior

An integrative approach to understanding the evolution and diversity of Copiapoa (Cactaceae), a threatened endemic Chilean genus from the Atacama Desert

Molecular phylogeny of the large South American genus Eriosyce (Notocacteae, Cactaceae): Generic delimitation and proposed changes in infrageneric and species ranks

Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes

PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors

Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial

Accelerated magnetocardiography in the evaluation of patients with suspected cardiac ischemia: The MAGNETO trial

Suchergebnisse filtern